Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab [4]

Annals of the Rheumatic Diseases

Volumn 66, Issue 10, 2007, Pages 1402-1403

  Gelinck, L B S ^a   Teng, Y K O ^a   Rimmelzwaan, G F ^b   Van Den Bemt, B J F ^c   Kroon, F P ^a   Van Laar, J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c St Maartenskliniek ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; METHOTREXATE; RITUXIMAB;

HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPROMISED PATIENT; INFLUENZA; INFLUENZA VACCINATION; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROLOGY;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INFLUENZA VACCINES; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34848904588     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.071878     Document Type: Letter

References (9)

1. Smith NM, Bresee JS, Shay DK, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55:1-42.
2. Chalmers A, Scheifele D, Patterson C, et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 1994;21:1203-6.
3. Edwards JC, Szczepanski L, Szechinski J, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004;350:2572-81.
4. Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JC. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:613-20.
5. Horwitz SM, Negrin RS, Blume KG, et al. Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood 2004;103:777-83.
6. van der Kolk LE, Baars JW, Prins MH, van Oers MH. Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood 2002;100:2257-9.
7. Palmer DF, Dowdle WR, Coleman MT, Schild GC. Haemagglutination- inhibition test, Advanced laboratory techniques for influenza diagnosis. Procedural guide. Atlanta, GA: US Department of Health, Education and Welfare, Public Health Service, Center for Disease Control, 1975:25-62.
8. Masurel N, Ophof P, de Jong P. Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus. J Hyg (Lond) 1981;87:201-9.
9. Oren C, Mendelbaum M, Paran D, et al. Vaccination against influenza in rheumatoid arthritis patients: the effect of rituximab on the humoral response. ACR 2006 abstract no. 1234.